Undifferentiated Connective Tissue Disease Recruiting Phase Trials for Nadroparin (DB08813)

IndicationStatusPhase
DBCOND0072477 (Undifferentiated Connective Tissue Disease)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03671174Immunosuppressant Regimens for Living Fetuses StudyTreatment